(FM) Oncología
Departamento académico
University of Cincinnati
Cincinnati, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Cincinnati (6)
2023
-
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions
International Journal of Gynecological Cancer, Vol. 33, Núm. 11, pp. 1733-1742
-
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
Gynecologic Oncology, Vol. 170, pp. 300-308
-
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: Multicenter, phase Ib dose escalation and expansion study
International Journal of Gynecological Cancer, Vol. 33, Núm. 4, pp. 562-570
2021
2019
-
Joint ENGOT and GOG Foundation requirements for trials with industry partners
International Journal of Gynecological Cancer, Vol. 29, Núm. 7, pp. 1094-1097
-
Joint ENGOT and GOG Foundation requirements for trials with industry partners
Gynecologic Oncology